TRAWbenzinga

Traws Reports Topline Results From Study Evaluating The Use Of Tivoxavir Marboxil As Treatment For Non-human Primates Challenged With Non-lethal Dose Of H5N1 Bird Flu; Results Build On Earlier Findings Of Mortality Benefit For TXM In Ferrets And Mice

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 24, 2025 by benzinga